Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade
Circulation · 2025
DOI: 10.1161/circulationaha.125.075057 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Circulation, 2025. Verfasst von Julian S Wanner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Germany (J.S.W., M.K., H.O.H.). Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Arrhythmias, Cardiac, Sodium Channel Blockers, Atrial Fibrillation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Atrial fibrillation and other cardiac arrhythmias pose a major public health burden, but prevention remains difficult. We investigated a genetic variant that we found to act like a natural lifelong cardiac sodium channel blockade. METHODS: We studied the impact of the Finnish-enriched SCN5A missense variant (rs45620037 [T220I]) on cardiac arrhythmias, associated mortality, and ECG phenotypes in a multicohort observational study with >1 million individuals across 3 cohorts (FinnGen, UK Biobank, and Health 2000). RESULTS: We identified protective effects of T220I on multiple common cardiac arrhythmias, most notably atrial fibrillation (cause-specific hazard ratio [HR], 0.56 [95% CI, 0.50–0.63]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Germany (J.S.W., M.K., H.O.H.).
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland (J.S.W., J.R., H.O.H.).
- Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland (T.N.).
- Department of Internal Medicine, Turku University Hospital and University of Turku, Finland (T.N.).
- Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam UMC, University of Amsterdam, the Netherlands (D.S.Z., S.J.J.).
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (P.T.E., S.J.J., J.R.).
ORCID-Profile: Julian S Wanner, Patrick T Ellinor, Girish Nadkarni, Sean J Jurgens, Joel Rämö, Henrike O Heyne
Zitieren
APA
Wanner, J. S., Krafft, M., Niiranen, T., Zimmerman, D. S., FinnGen, Ellinor, P. T., Nadkarni, G., Jurgens, S. J., Rämö, J., & Heyne, H. O. (2025). Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade. Circulation. https://doi.org/10.1161/circulationaha.125.075057
Vancouver
Wanner JS, Krafft M, Niiranen T, Zimmerman DS, FinnGen, Ellinor PT, et al. Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade. Circulation. 2025. doi:10.1161/circulationaha.125.075057
BibTeX
@article{Wanner2025,
author = {Wanner, Julian S and Krafft, Maren and Niiranen, Teemu and Zimmerman, Dominic S and FinnGen and Ellinor, Patrick T and Nadkarni, Girish and Jurgens, Sean J and Rämö, Joel and Heyne, Henrike O},
title = {Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade},
journal = {Circulation},
year = {2025},
doi = {10.1161/circulationaha.125.075057}
}
EUVIMED